These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33578115)

  • 1. Electrochemical biosensors for biometal-protein interactions in neurodegenerative diseases.
    Li S; Kerman K
    Biosens Bioelectron; 2021 May; 179():113035. PubMed ID: 33578115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
    Tabner BJ; Turnbull S; El-Agnaf O; Allsop D
    Curr Top Med Chem; 2001 Dec; 1(6):507-17. PubMed ID: 11895127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.
    Calderón-Garcidueñas L; Avila-Ramírez J; Calderón-Garcidueñas A; González-Heredia T; Acuña-Ayala H; Chao CK; Thompson C; Ruiz-Ramos R; Cortés-González V; Martínez-Martínez L; García-Pérez MA; Reis J; Mukherjee PS; Torres-Jardón R; Lachmann I
    J Alzheimers Dis; 2016 Sep; 54(2):597-613. PubMed ID: 27567860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Tau and α-Synuclein Pathology in the Visual System.
    Rahimi J; Milenkovic I; Kovacs GG
    J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein.
    McAllister BB; Lacoursiere SG; Sutherland RJ; Mohajerani MH
    Neurosci Biobehav Rev; 2020 May; 112():1-27. PubMed ID: 31996301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crosstalk between metals and neurodegenerative diseases].
    Kawahara M; Mizuno D
    Nihon Eiseigaku Zasshi; 2014; 69(3):155-65. PubMed ID: 25253517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cellular prion protein in interneuronal amyloid transmission.
    Del Río JA; Ferrer I; Gavín R
    Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosensors in Parkinson's disease.
    Mobed A; Razavi S; Ahmadalipour A; Shakouri SK; Koohkan G
    Clin Chim Acta; 2021 Jul; 518():51-58. PubMed ID: 33753044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides.
    Kumar D; Kumar P
    Neuropeptides; 2019 Dec; 78():101971. PubMed ID: 31540705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.
    Baldacci F; Daniele S; Piccarducci R; Giampietri L; Pietrobono D; Giorgi FS; Nicoletti V; Frosini D; Libertini P; Lo Gerfo A; Petrozzi L; Donadio E; Betti L; Trincavelli ML; Siciliano G; Ceravolo R; Tognoni G; Bonuccelli U; Martini C
    Mol Neurobiol; 2019 Sep; 56(9):6451-6459. PubMed ID: 30826968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrochemical biosensors for the detection and study of α-synuclein related to Parkinson's disease - A review.
    Hassan Q; Li S; Ferrag C; Kerman K
    Anal Chim Acta; 2019 Dec; 1089():32-39. PubMed ID: 31627816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
    Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
    Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enlightening the advancements in electrochemical bioanalysis for the diagnosis of Alzheimer's disease and other neurodegenerative disorders.
    Serafín V; Gamella M; Pedrero M; Montero-Calle A; Razzino CA; Yáñez-Sedeño P; Barderas R; Campuzano S; Pingarrón JM
    J Pharm Biomed Anal; 2020 Sep; 189():113437. PubMed ID: 32629192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein.
    Albus A; Gold M; Bach JP; Burg-Roderfeld M; Jördens M; Kirchhein Y; Kronimus Y; Mengel D; Zerr I; Dodel R
    PLoS One; 2018; 13(8):e0202954. PubMed ID: 30157279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease.
    Duyckaerts C; Clavaguera F; Potier MC
    Curr Opin Neurol; 2019 Apr; 32(2):266-271. PubMed ID: 30724769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology.
    Førland MG; Tysnes OB; Aarsland D; Maple-Grødem J; Pedersen KF; Alves G; Lange J
    Eur J Neurol; 2020 Jan; 27(1):43-50. PubMed ID: 31293044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases.
    Kawahara M; Kato-Negishi M; Tanaka K
    Metallomics; 2017 Jun; 9(6):619-633. PubMed ID: 28516990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.